Prostate Cancer Expression Profiles Reveals Pathway Dysregulation in Meta-Analysis of Microarrays : Interstudy Validation of Gene Updated
暂无分享,去创建一个
[1] N. Sampas,et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.
[2] 中尾 光輝,et al. KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .
[3] E. Dougherty,et al. Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.
[4] K. Furge,et al. Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[6] J. Herman,et al. A gene hypermethylation profile of human cancer. , 2001, Cancer research.
[7] S. Dhanasekaran,et al. Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.
[8] [Detection of urinary polyamine by a new enzymatic differential assay. (III). Studies on urinary polyamines in patients with malignant genitourinary diseases]. , 1986, Hinyokika kiyo. Acta urologica Japonica.
[9] M. Bittner,et al. Expression profiling in cancer using cDNA microarrays , 1999, Electrophoresis.
[10] Bettuzzi Saverio,et al. Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens. , 2000 .
[11] T. Thomas,et al. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications , 2001, Cellular and Molecular Life Sciences CMLS.
[12] C. McLaren,et al. Alpha-difluoromethylornithine and polyamine levels in the human prostate: results of a phase IIa trial. , 2001, Journal of the National Cancer Institute.
[13] J. Welsh,et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. , 2001, Cancer research.
[14] M. Bittner,et al. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. , 2001, Cancer research.
[15] L. D. Smith,et al. Adenylosuccinate lyase as an indicator of breast and prostate malignancies: a preliminary report. , 1987, Clinical biochemistry.
[16] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[17] A. Sinha,et al. Gene expression profile analysis by DNA microarrays: promise and pitfalls. , 2001, JAMA.
[18] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[19] J. Neefs,et al. Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation , 2000, British Journal of Cancer.
[20] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[21] Jeffrey A. Magee,et al. Expression profiling reveals hepsin overexpression in prostate cancer. , 2001, Cancer research.